Pavmed subsidiary Lucid Diagnostics files registration statement for IPO - NewsBreak

The number of shares of common stock and the price range for the offering have not yet been determined, according to a news release. Lucid Diagnostics intends to list its common stock on the Nasdaq market under the "LUCD" ticker. Cantor Fitzgerald & Co. and Canaccord Genuity LLC will act...